764 related articles for article (PubMed ID: 23713876)
1. Vitamin D metabolites and/or analogs: which D for which patient?
Mazzaferro S; Goldsmith D; Larsson TE; Massy ZA; Cozzolino M
Curr Vasc Pharmacol; 2014 Mar; 12(2):339-49. PubMed ID: 23713876
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D analogues for the management of secondary hyperparathyroidism.
Martin KJ; González EA
Am J Kidney Dis; 2001 Nov; 38(5 Suppl 5):S34-40. PubMed ID: 11689385
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
6. Clinical uses of 1-alpha-hydroxy-ergocalciferol.
Park J; Rhee CM; Lau WL; Kalantar-Zadeh K
Curr Vasc Pharmacol; 2014 Mar; 12(2):306-12. PubMed ID: 23713877
[TBL] [Abstract][Full Text] [Related]
7. What is the optimal regimen for vitamin D?
Cunningham J
Kidney Int Suppl; 1999 Dec; 73():S59-64. PubMed ID: 10633466
[TBL] [Abstract][Full Text] [Related]
8. Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease.
Galassi A; Bellasi A; Ciceri P; Pivari F; Conte F; Cozzolino M
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1073-1084. PubMed ID: 28846459
[TBL] [Abstract][Full Text] [Related]
9. Mortality risk among hemodialysis patients receiving different vitamin D analogs.
Tentori F; Hunt WC; Stidley CA; Rohrscheib MR; Bedrick EJ; Meyer KB; Johnson HK; Zager PG;
Kidney Int; 2006 Nov; 70(10):1858-65. PubMed ID: 17021609
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.
Lau KH; Baylink DJ
Calcif Tissue Int; 1999 Oct; 65(4):295-306. PubMed ID: 10485982
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D analogs: new therapeutic agents for secondary hyperparathyroidism.
Brown AJ; Coyne DW
Treat Endocrinol; 2002; 1(5):313-27. PubMed ID: 15832485
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D analogs for the treatment of secondary hyperparathyroidism.
Slatopolsky E; Brown AJ
Blood Purif; 2002; 20(1):109-12. PubMed ID: 11803167
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D analogs as therapeutic agents: a clinical study update.
Wu-Wong JR; Tian J; Goltzman D
Curr Opin Investig Drugs; 2004 Mar; 5(3):320-6. PubMed ID: 15083599
[TBL] [Abstract][Full Text] [Related]
14. A randomised clinical study of alfacalcidol and paricalcitol.
Hansen D
Dan Med J; 2012 Feb; 59(2):B4400. PubMed ID: 22293059
[TBL] [Abstract][Full Text] [Related]
15. Native vitamin D in pre-dialysis chronic kidney disease.
Cardoso MP; Pereira LAL
Nefrologia (Engl Ed); 2019; 39(1):18-28. PubMed ID: 30274806
[TBL] [Abstract][Full Text] [Related]
16. Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol.
Hansen D; Brandi L; Rasmussen K
BMC Nephrol; 2009 Sep; 10():28. PubMed ID: 19778452
[TBL] [Abstract][Full Text] [Related]
17. Strategies to minimize bone disease in renal failure.
Martin KJ; González EA
Am J Kidney Dis; 2001 Dec; 38(6):1430-6. PubMed ID: 11728986
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis and treatment of secondary hyperparathyroidism in dialysis patients: the role of paricalcitol.
Cozzolino M; Galassi A; Gallieni M; Brancaccio D
Curr Vasc Pharmacol; 2008 Apr; 6(2):148-53. PubMed ID: 18393917
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2011 Jul; (7):CD007470. PubMed ID: 21735411
[TBL] [Abstract][Full Text] [Related]
20. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
